Madhurima Basak1, Tamalika Sanyal2,3, Anish Kar1, Pritha Bhattacharjee3, Madhusudan Das2, Subhankar Chowdhury4. 1. Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata, 700020, West Bengal, India. 2. Department of Zoology, University of Calcutta, Kolkata, 700019, India. 3. Department of Environmental Science, University of Calcutta, Kolkata, 700019, India. 4. Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata, 700020, West Bengal, India. subhankar.chowdhury@gmail.com.
Abstract
PURPOSE: Graves' disease (GD) is an autoimmune disorder affecting primarily the thyroid gland. The most common extrathyroidal manifestation of GD is known as Graves' orbitopathy (GO). Bone marrow-derived fibrocytes represent a subset of monocytes in peripheral blood mononuclear cells (PBMCs), infiltrate the orbital tissues, and contribute to the pathogenesis of GO. Hence objectives of the study included whether the concentration of fibrocytes in peripheral blood was higher in GO, whether TSHR m RNA expression and TSHR surface expression in peripheral blood were higher in GO in comparison to Graves' Disease (GD) and Control subjects. METHODS: The percentage of circulating fibrocytes (FC) along with TSHR on its cell surface (CD 34+, CD 45+, CXCR4+, Collagen 1+, TSHR+) were assessed by flow cytometry of 50 patients with GD and GO and 15 healthy donors (Control). TSHR mRNA expression was measured by q RT PCR. RESULT: The concentration of circulating fibrocytes was significantly higher in GO compared to GD and control [GO 17% vs GD 3% vs control 0.7% (p < 0.05)]. Moreover, these fibrocytes express a significantly higher level of TSHR in GO. This was corroborated by the measure of TSH mRNA; in GD it was 2.3-fold higher and in GO it was 3.9 fold higher than in control, in GO this transcript level was 1.7fold higher than GD (p < 0.05). TSHR+ fibrocytes were significantly positively correlated with CAS (p = 0.004) and negatively correlated with age (p = 0.01) and duration of disease (p = 0.01) in GO. CONCLUSION: This study sheds further light on the pathogenesis of GO.
PURPOSE: Graves' disease (GD) is an autoimmune disorder affecting primarily the thyroid gland. The most common extrathyroidal manifestation of GD is known as Graves' orbitopathy (GO). Bone marrow-derived fibrocytes represent a subset of monocytes in peripheral blood mononuclear cells (PBMCs), infiltrate the orbital tissues, and contribute to the pathogenesis of GO. Hence objectives of the study included whether the concentration of fibrocytes in peripheral blood was higher in GO, whether TSHR m RNA expression and TSHR surface expression in peripheral blood were higher in GO in comparison to Graves' Disease (GD) and Control subjects. METHODS: The percentage of circulating fibrocytes (FC) along with TSHR on its cell surface (CD 34+, CD 45+, CXCR4+, Collagen 1+, TSHR+) were assessed by flow cytometry of 50 patients with GD and GO and 15 healthy donors (Control). TSHR mRNA expression was measured by q RT PCR. RESULT: The concentration of circulating fibrocytes was significantly higher in GO compared to GD and control [GO 17% vs GD 3% vs control 0.7% (p < 0.05)]. Moreover, these fibrocytes express a significantly higher level of TSHR in GO. This was corroborated by the measure of TSH mRNA; in GD it was 2.3-fold higher and in GO it was 3.9 fold higher than in control, in GO this transcript level was 1.7fold higher than GD (p < 0.05). TSHR+ fibrocytes were significantly positively correlated with CAS (p = 0.004) and negatively correlated with age (p = 0.01) and duration of disease (p = 0.01) in GO. CONCLUSION: This study sheds further light on the pathogenesis of GO.
Authors: Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas Journal: J Clin Endocrinol Metab Date: 2011-09-28 Impact factor: 5.958
Authors: Erin F Gillespie; Konstantinos I Papageorgiou; Roshini Fernando; Nupur Raychaudhuri; Kimberly P Cockerham; Laya K Charara; Allan C P Goncalves; Shuang-Xia Zhao; Anna Ginter; Ying Lu; Terry J Smith; Raymond S Douglas Journal: J Clin Endocrinol Metab Date: 2012-03-07 Impact factor: 5.958
Authors: E Macchia; G F Fenzi; F Monzani; L Bartalena; F Lippi; V Aloisio; C Cupini; L Baschieri; A Pinchera Journal: J Endocrinol Invest Date: 1983-10 Impact factor: 4.256
Authors: Raymond S Douglas; Nikoo F Afifiyan; Catherine J Hwang; Kelvin Chong; Uzma Haider; Patrick Richards; Andrew G Gianoukakis; Terry J Smith Journal: J Clin Endocrinol Metab Date: 2009-11-06 Impact factor: 5.958
Authors: Antje Moeller; Sarah E Gilpin; Kjetil Ask; Gerard Cox; Deborah Cook; Jack Gauldie; Peter J Margetts; Laszlo Farkas; Julian Dobranowski; Colm Boylan; Paul M O'Byrne; Robert M Strieter; Martin Kolb Journal: Am J Respir Crit Care Med Date: 2009-01-16 Impact factor: 21.405
Authors: Priya Chinnappa; Leslie Taguba; Rosemarie Arciaga; Charles Faiman; Allan Siperstein; Adi E Mehta; Sethu K Reddy; Christian Nasr; Manjula K Gupta Journal: J Clin Endocrinol Metab Date: 2004-08 Impact factor: 5.958